drugset / Trial / NCT00862459
Dose Finding Study of Gadavist in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)
RandomizedParallel-groupTriple-blindDiagnostic
Summary
The purpose of this study is to look at the safety (what are the side effects) and efficacy (how well does it work) of Gadavist when used for taking images of the brain and spine. The results of the MRI with Gadavist Injection will be compared to the results of MR images taken without contrast and with the results of the MR images taken with OptiMARK.
Timeline
- Start
- 2005-08
- Primary completion
- 2007-03
- Completion
- 2007-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gadobutrol | Diagnostic / imaging agent | 0.03 mmol | Intravenous |
| Subject | Gadobutrol | Diagnostic / imaging agent | 0.1 mmol | Intravenous |
| Subject | Gadobutrol | Diagnostic / imaging agent | 0.3 mmol | Intravenous |
| Subject | Gadoversetamide | Diagnostic / imaging agent | 0.1 mmol | — |